{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:04:30Z","timestamp":1788984270220,"version":"build-2803163510"},"reference-count":71,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T00:00:00Z","timestamp":1551312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4,1]]},"DOI":"10.1093\/cvr\/cvz042","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T19:56:09Z","timestamp":1551210969000},"page":"713-720","source":"Crossref","is-referenced-by-count":24,"title":["Tumour necrosis factor superfamily members in ischaemic vascular diseases"],"prefix":"10.1093","volume":"115","author":[{"given":"Megan","family":"Nash","sequence":"first","affiliation":[{"name":"Heart Research Institute, 7 Eliza Street, Newtown, Sydney NSW, Australia"},{"name":"School of Medical Sciences, University of Sydney, Camperdown, NSW, Australia"},{"name":"Department of Biochemistry, University of Bath, Bath, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan P","family":"McGrath","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Royal Prince Alfred Hospital, Missenden Rd Camperdown, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si\u00e2n P","family":"Cartland","sequence":"additional","affiliation":[{"name":"Heart Research Institute, 7 Eliza Street, Newtown, Sydney NSW, Australia"},{"name":"School of Medical Sciences, University of Sydney, Camperdown, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Patel","sequence":"additional","affiliation":[{"name":"Heart Research Institute, 7 Eliza Street, Newtown, Sydney NSW, Australia"},{"name":"School of Medical Sciences, University of Sydney, Camperdown, NSW, Australia"},{"name":"Department of Cardiology, Royal Prince Alfred Hospital, Missenden Rd Camperdown, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary M","family":"Kavurma","sequence":"additional","affiliation":[{"name":"Heart Research Institute, 7 Eliza Street, Newtown, Sydney NSW, Australia"},{"name":"School of Medical Sciences, University of Sydney, Camperdown, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,2,28]]},"reference":[{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B1","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1161\/ATVBAHA.107.155143","article-title":"Death receptors and their ligands in atherosclerosis","volume":"28","author":"Kavurma","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B2","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/ni.2065","article-title":"Crosstalk in NF-[kappa]B signaling pathways","volume":"12","author":"Oeckinghaus","year":"2011","journal-title":"Nat Immunol"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B3","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.4049\/jimmunol.0803357","article-title":"Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) activates proinflammatory signaling pathways and gene expression through the activation of TGF-beta activated kinase 1","volume":"182","author":"Kumar","year":"2009","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B4","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","article-title":"Molecular mechanism and function of CD40\/CD40L engagement in the immune system","volume":"229","author":"Elgueta","year":"2009","journal-title":"Immunol Rev"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B5","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/eurheartj\/eht367","article-title":"Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis","volume":"35","author":"Kaptoge","year":"2014","journal-title":"E Heart J"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B6","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1399-0039.2009.01332.x","article-title":"Plasma concentrations of TNF-\u03b1 and its soluble receptors sTNFR1 and sTNFR2 in patients with coronary artery disease","volume":"74","author":"Safranow","year":"2009","journal-title":"Tissue Antigens"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.yjmcc.2014.02.012","article-title":"TNF-alpha promotes early atherosclerosis by increasing transcytosis of LDL across endothelial cells: crosstalk between NF-kappaB and PPAR-gamma","volume":"72","author":"Zhang","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ymgme.2008.11.166","article-title":"Tumor necrosis factor-alpha deficiency retards early fatty-streak lesion by influencing the expression of inflammatory factors in apoE-null mice","volume":"96","author":"Xiao","year":"2009","journal-title":"Mol Genet Metab"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B9","doi-asserted-by":"crossref","first-page":"53.","DOI":"10.1186\/s12929-015-0165-8","article-title":"Tumor necrosis factor-alpha induces VCAM-1-mediated inflammation via c-Src-dependent transactivation of EGF receptors in human cardiac fibroblasts","volume":"22","author":"Lin","year":"2015","journal-title":"J Biomed Sci"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B10","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1476-5381.1996.tb16017.x","article-title":"Tumour necrosis factor-alpha-induced ICAM-1 expression in human vascular endothelial and lung epithelial cells: modulation by tyrosine kinase inhibitors","volume":"119","author":"Burke-Gaffney","year":"1996","journal-title":"Br J Pharmacol"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B11","doi-asserted-by":"crossref","first-page":"L1232.","DOI":"10.1152\/ajplung.00109.2006","article-title":"TNF-\u03b1 increases tyrosine phosphorylation of vascular endothelial cadherin and opens the paracellular pathway through fyn activation in human lung endothelia","volume":"291","author":"Angelini","year":"2006","journal-title":"Am J Physiol - Lung Cell Mol Phys"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bbrc.2014.12.070","article-title":"Glatiramer acetate (GA) prevents TNF-alpha-induced monocyte adhesion to primary endothelial cells through interfering with the NF-kappaB pathway","volume":"457","author":"Wei","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B13","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1194\/jlr.M800484-JLR200","article-title":"TNF-alpha stimulates the ACAT1 expression in differentiating monocytes to promote the CE-laden cell formation","volume":"50","author":"Lei","year":"2009","journal-title":"J Lipid Res"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B14","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/abbs\/gmv092","article-title":"Excess TNF-alpha in the blood activates monocytes with the potential to directly form cholesteryl ester-laden cells","volume":"47","author":"Zhu","year":"2015","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B15","doi-asserted-by":"crossref","first-page":"1567.","DOI":"10.3390\/ijms17091567","article-title":"Advanced glycation end-products induce apoptosis of vascular smooth muscle cells: a mechanism for vascular calcification","volume":"17","author":"Koike","year":"2016","journal-title":"IJMS"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B16","doi-asserted-by":"crossref","first-page":"1529.","DOI":"10.1161\/CIRCRESAHA.108.175976","article-title":"Chronic apoptosis of vascular smooth muscle cells accelerates atherosclerosis and promotes calcification and medial degeneration","volume":"102","author":"Clarke","year":"2008","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B17","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1177\/1358863X15597076","article-title":"The association of bone and osteoclasts with vascular calcification","volume":"20","author":"Han","year":"2015","journal-title":"Vasc Med"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B18","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1161\/01.CIR.102.21.2636","article-title":"Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway","volume":"102","author":"Tintut","year":"2000","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.trsl.2007.12.005","article-title":"Arterial calcification: a tumor necrosis factor-alpha mediated vascular Wnt-opathy","volume":"151","author":"Al-Aly","year":"2008","journal-title":"Transl Res"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B20","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.atherosclerosis.2016.05.044","article-title":"Calcification of vascular smooth muscle cells is induced by secondary calciprotein particles and enhanced by tumor necrosis factor-alpha","volume":"251","author":"Aghagolzadeh","year":"2016","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B21","doi-asserted-by":"crossref","first-page":"26174","DOI":"10.1074\/jbc.271.42.26174","article-title":"Accelerated atherosclerosis in mice lacking tumor necrosis factor receptor p55","volume":"271","author":"Schreyer","year":"1996","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B22","doi-asserted-by":"crossref","first-page":"e6113.","DOI":"10.1371\/journal.pone.0006113","article-title":"Absence of p55 TNF receptor reduces atherosclerosis, but has no major effect on angiotensin II induced aneurysms in LDL receptor deficient mice","volume":"4","author":"Xanthoulea","year":"2009","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B23","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.bcp.2007.10.020","article-title":"Expression, regulation and function of trail in atherosclerosis","volume":"75","author":"Kavurma","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B24","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.4049\/jimmunol.171.3.1526","article-title":"TRAIL induces apoptosis and inflammatory gene expression in human endothelial cells","volume":"171","author":"Li","year":"2003","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B25","doi-asserted-by":"crossref","first-page":"1898.","DOI":"10.1038\/s41598-017-01721-4","article-title":"Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice","volume":"7","author":"Cartland","year":"2017","journal-title":"Sci Rep"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B26","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1161\/CIRCRESAHA.109.206029","article-title":"TRAIL promotes VSMC proliferation and neointima formation in a FGF-2-, Sp1 phosphorylation-, and NFkappaB-dependent manner","volume":"106","author":"Chan","year":"2010","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B27","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1007\/s00125-011-2308-0","article-title":"TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe \u2212\/\u2212 mice","volume":"54","author":"Di Bartolo","year":"2011","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B28","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1161\/CIRCULATIONAHA.106.643841","article-title":"Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice","volume":"114","author":"Secchiero","year":"2006","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B29","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.freeradbiomed.2018.08.031","article-title":"TRAIL protects against endothelial dysfunction in vivo and inhibits angiotensin-II-induced oxidative stress in vascular endothelial cells in vitro","volume":"126","author":"Manuneedhi Cholan","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B30","doi-asserted-by":"crossref","first-page":"e002527","DOI":"10.1161\/JAHA.115.002527","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) promotes angiogenesis and ischemia-induced neovascularization via NADPH oxidase 4 (NOX4) and nitric oxide-dependent mechanisms","volume":"4","author":"Di Bartolo","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B31","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.3390\/ijms17122025","article-title":"Comparative evaluation of TRAIL, FGF-2 and VEGF-A-induced angiogenesis in vitro and in vivo","volume":"17","author":"Cartland","year":"2016","journal-title":"Int J Mol Sci"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B32","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1593\/neo.03421","article-title":"Evidence for a proangiogenic activity of TNF-related apoptosis-inducing ligand","volume":"6","author":"Secchiero","year":"2004","journal-title":"Neoplasia"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B33","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1161\/01.RES.0000067928.83455.9C","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sequentially upregulates nitric oxide and prostanoid production in primary human endothelial cells","volume":"92","author":"Zauli","year":"2003","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B34","doi-asserted-by":"crossref","first-page":"e74211.","DOI":"10.1371\/journal.pone.0074211","article-title":"TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL","volume":"8","author":"Di Bartolo","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B35","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.atherosclerosis.2010.11.004","article-title":"Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults","volume":"215","author":"Volpato","year":"2011","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B36","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1161\/01.STR.0000230648.00027.00","article-title":"Fn14 is upregulated in cytokine-stimulated vascular smooth muscle cells and is expressed in human carotid atherosclerotic plaques","volume":"37","author":"Mu\u00f1oz-Garc\u00eda","year":"2006","journal-title":"Stroke"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B37","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0006-291X(02)02670-0","article-title":"Pro-inflammatory effect of TWEAK\/Fn14 interaction on human umbilical vein endothelial cells","volume":"299","author":"Harada","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B38","doi-asserted-by":"crossref","first-page":"e2305.","DOI":"10.1038\/cddis.2016.220","article-title":"TWEAK favors phosphate-induced calcification of vascular smooth muscle cells through canonical and non-canonical activation of NF\u03baB","volume":"7","author":"H\u00e9naut","year":"2016","journal-title":"Cell Death Dis"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B39","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2215\/CJN.07900715","article-title":"Soluble TWEAK and major adverse cardiovascular events in patients with CKD","volume":"11","author":"Fern\u00e1ndez-Laso","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B40","doi-asserted-by":"crossref","first-page":"612.","DOI":"10.1161\/ATVBAHA.112.300874","article-title":"HMGB1 expression and secretion are increased via TWEAK\u2013Fn14 interaction in atherosclerotic plaques and cultured monocytes","volume":"33","author":"Moreno","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B41","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1161\/ATVBAHA.109.195040","article-title":"Fn14-Fc fusion protein regulates atherosclerosis in ApoE-\/- mice and inhibits macrophage lipid uptake in vitro","volume":"29","author":"Schapira","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B42","doi-asserted-by":"crossref","first-page":"46679.","DOI":"10.1038\/srep46679","article-title":"TWEAK blockade decreases atherosclerotic lesion size and progression through suppression of STAT1 signaling in diabetic mice","volume":"7","author":"Fern\u00e1ndez-Laso","year":"2017","journal-title":"Sci Rep"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B43","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1182\/blood-2008-03-143479","article-title":"Soluble CD40 ligand induces endothelial dysfunction in human and porcine coronary artery endothelial cells","volume":"112","author":"Chen","year":"2008","journal-title":"Blood"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B44","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1073\/pnas.94.5.1931","article-title":"Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40\u2013CD40 ligand signaling in\u2009atherosclerosis","volume":"94","author":"Mach","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B45","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/35393","article-title":"CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells","volume":"391","author":"Henn","year":"1998","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B46","doi-asserted-by":"crossref","first-page":"7464","DOI":"10.1073\/pnas.97.13.7464","article-title":"Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype","volume":"97","author":"Lutgens","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B47","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/28204","article-title":"Reduction of atherosclerosis in mice by inhibition of CD40 signalling","volume":"394","author":"Mach","year":"1998","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B48","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1084\/jem.20091293","article-title":"Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile","volume":"207","author":"Lutgens","year":"2010","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B49","doi-asserted-by":"crossref","first-page":"38.","DOI":"10.1007\/s00395-016-0554-5","article-title":"CD40 in coronary artery disease: a matter of macrophages?","volume":"111","author":"Jansen","year":"2016","journal-title":"Basic Res Cardiol"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000374105","article-title":"Soluble CD40 ligand promotes macrophage foam cell formation in the etiology of atherosclerosis","volume":"131","author":"Yuan","year":"2015","journal-title":"Cardiology"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B51","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2174\/1871523011312010009","article-title":"Biologics and the cardiovascular system: a double-edged sword","volume":"12","author":"Roubille","year":"2013","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B52","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1080\/14740338.2018.1483331","article-title":"Cardiovascular risk factors in patients with rheumatoid arthritis prescribed disease modifying anti-rheumatic drugs","volume":"17","author":"Giollo","year":"2018","journal-title":"Expert Opin Drug Saf"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B53","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1056\/NEJMct055183","article-title":"Tumor necrosis factor inhibitors for rheumatoid arthritis","volume":"355","author":"Scott","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B54","article-title":"Do TNF inhibitors directly affect cardiovascular risk?","author":"Coblyn","year":"2016","journal-title":"NEJM J Watch Gen Med"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B55","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1002\/art.22809","article-title":"Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti\u2013tumor necrosis factor \u03b1 therapy: results from the British Society for Rheumatology Biologics Register","volume":"56","author":"Dixon","year":"2007","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B56","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/annrheumdis-2016-209784","article-title":"Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis","volume":"76","author":"Low","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B57","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/acr.20371","article-title":"Systematic review and meta-analysis: anti\u2013tumor necrosis factor \u03b1 therapy and cardiovascular events in rheumatoid arthritis","volume":"63","author":"Barnabe","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B58","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","article-title":"The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"74","author":"Roubille","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B59","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1136\/annrheumdis-2015-208995","article-title":"Response to biological treatment and subsequent risk of coronary events in rheumatoid arthritis","volume":"75","author":"Ljung","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B60","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/annrheumdis-2012-eular.3087","article-title":"SAT0140 The risk of acute coronary syndromes in RA in relation to TNF inhibitors and risks in the general population: a national cohort study","volume":"71","author":"Ljung","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B61","doi-asserted-by":"crossref","first-page":"171.","DOI":"10.1186\/s13075-018-1669-x","article-title":"Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study","volume":"20","author":"Lee","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B62","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/cvr\/cvy145","article-title":"Immunomodulatory interventions in myocardial infarction and heart failure: a systematic review of clinical trials and meta-analysis of IL-1 inhibition","volume":"114","author":"Panahi","year":"2018","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B63","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","article-title":"Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-\u03b1, in patients with moderate-to-severe heart failure: results of the anti-TNF therapy against congestive heart failure (ATTACH) trial","volume":"107","author":"Chung","year":"2003","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B64","doi-asserted-by":"crossref","first-page":"733.","DOI":"10.1038\/cdd.2015.174","article-title":"Onto better TRAILs for cancer treatment","volume":"23","author":"De Miguel","year":"2016","journal-title":"Cell Death Differ"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B65","doi-asserted-by":"crossref","first-page":"352.","DOI":"10.1038\/nrc.2017.28","article-title":"Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy","volume":"17","author":"von Karstedt","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B66","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/bcp.12914","article-title":"Population pharmacokinetic and pharmacodynamic analysis of BIIB023, an anti\u2010TNF\u2010like weak inducer of apoptosis (anti\u2010TWEAK) monoclonal antibody","volume":"82","author":"Galluppi","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B67","article-title":"Evaluation of the efficacy, safety, and tolerability of BIIB023 as an adjunct to standard of care in subjects with lupus nephritis [abstract]","volume":"68","author":"Furie","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B68","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1158\/1535-7163.MCT-17-0330","article-title":"Phase I study of enavatuzumab, a first-in-class humanized monoclonal antibody targeting the TWEAK receptor, in patients with advanced solid tumors","volume":"17","author":"Lam","year":"2018","journal-title":"Mol Cancer Ther"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B69","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/art.10856","article-title":"A short course of BG9588 (anti\u2013CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis","volume":"48","author":"Boumpas","year":"2003","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B70","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1191\/0961203304lu1032oa","article-title":"Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients","volume":"13","author":"Sidiropoulos","year":"2004","journal-title":"Lupus"},{"key":"key\n\t\t\t\t2019040308500388000_cvz042-B71","first-page":"535","volume-title":"CD40 as a Therapeutic Target in Sj\u00f6gren\u2019s Syndrome. Expert Rev Clin Immunol","author":"Jobling","year":"2018"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cardiovascres\/article-pdf\/115\/4\/713\/28268176\/cvz042.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T09:05:31Z","timestamp":1554282331000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article\/115\/4\/713\/5366704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,28]]},"references-count":71,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,2,28]]},"published-print":{"date-parts":[[2019,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvz042","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,4,1]]},"published":{"date-parts":[[2019,2,28]]}}}